I’ve Lived with Breast Cancer for 14 YEARS! | Janice's Patient Story

[lerolob428]

The prognosis initially felt very bleak, with a median overall survival estimated at around 9 to 15 months. Faced with that reality, the question became how to make the most of the time ahead. Janice was first diagnosed with breast cancer in 2011 and, after successful surgery and treatment, gradually returned to normal life within two to three years. She and her husband resumed traveling and celebrated joyful milestones, including the arrival of their first grandchild.

Five years later, the cancer returned. Despite receiving a stage four diagnosis, Janice chose to focus on living meaningfully while supporting others facing breast cancer. She dedicated her time to helping patients understand their disease, locate reliable resources, and find emotional support.

Like many patients, Janice first noticed a small lump shortly before her annual mammogram. Although it was tender and initially thought unlikely to be cancer, she reported it during her appointment. Following imaging, a biopsy confirmed triple-negative breast cancer. With no family history of breast cancer, the diagnosis came as a complete surprise.

She was diagnosed with stage one breast cancer and underwent a lumpectomy followed by brachytherapy radiation, where a small balloon device delivered radiation directly to the surgical cavity twice daily for five days. A month later, she began chemotherapy. After completing treatment, she returned to everyday life, though fear of recurrence remained emotionally challenging, especially during the first two years.

Reaching the third year after treatment brought some relief, as recurrence risk is often highest during that period for triple-negative breast cancer. Unaware that about 30% of early-stage breast cancer patients may eventually experience metastatic recurrence, Janice gradually placed cancer behind her and embraced life again through travel and family time.

During a routine five-year follow-up appointment, she mentioned persistent bone and joint pain. Her oncologist ordered a PET scan, which revealed a recurrence of cancer. The disease had spread to regional lymph nodes and a node on the opposite side, classifying it as stage four metastatic breast cancer. The news came as a devastating shock, leaving both Janice and her husband speechless.

Drawing on her background as a retired pediatric nurse, Janice began researching metastatic triple-negative breast cancer using trusted medical sources. The outlook appeared discouraging, and difficult conversations with family followed as she explained the seriousness of her prognosis. Many people mistakenly believe all breast cancers are the same or easily treatable, a misconception she quickly learned was untrue.

Following her oncologist’s recommendation, Janice began combination chemotherapy. At the time, targeted therapies and immunotherapy options were limited compared to those available today. After several treatment cycles, scans showed no visible evidence of disease, and her care team shifted to close monitoring.

Seeking reassurance, Janice pursued second opinions after attending a breast cancer conference that emphasized their importance. She later began treatment at MD Anderson Cancer Center, where she found a medical oncologist who became a trusted long-term partner in her care. Years later, her condition stabilized to the point where scans were needed only once a year.

Throughout her journey, Janice discovered the powerful role of connection and peer support. Living with metastatic breast cancer can feel isolating, and she believes community support—whether online or in person—is essential. She encourages patients to seek reliable information, remain cautious of misinformation, and always consult healthcare professionals when uncertain.

Motivated to help others, Janice became Director of Peer-to-Peer programs at METAvivor, helping train leaders to establish local support groups. She also founded an online community specifically for people newly diagnosed with metastatic breast cancer, creating a safe space where patients can ask questions, learn together, and connect without fear or pressure.

Over the years, she has witnessed significant progress in breast cancer treatment. Although advancements for triple-negative breast cancer still lag behind some other subtypes, the growing number of targeted therapies and new drug approvals offers increasing hope.

Janice’s message to others is clear: a metastatic breast cancer diagnosis is not an immediate death sentence. Hope exists, even during the hardest moments. Learning about one’s specific disease, understanding available treatments, and practicing self-advocacy are essential steps. Patients do not need to know everything or become advocates, but gaining basic knowledge empowers them to make informed decisions and actively participate in their care.